181 related articles for article (PubMed ID: 35122575)
1. Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial.
Beesham I; Joseph Davey DL; Beksinska M; Bosman S; Smit J; Mansoor LE
AIDS Behav; 2022 Aug; 26(8):2623-2631. PubMed ID: 35122575
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial.
Beesham I; Heffron R; Evans S; Baeten JM; Smit J; Beksinska M; Mansoor LE
AIDS Behav; 2021 Apr; 25(4):1112-1119. PubMed ID: 33106996
[TBL] [Abstract][Full Text] [Related]
3. Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa.
Beesham I; Milford C; Smit J; Joseph Davey DL; Baeten JM; Heffron R; Beksinska M; Mansoor LE
BMC Public Health; 2023 Jun; 23(1):1210. PubMed ID: 37349816
[TBL] [Abstract][Full Text] [Related]
4. Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial.
Beesham I; Welch JD; Heffron R; Pleaner M; Kidoguchi L; Palanee-Phillips T; Ahmed K; Baron D; Bukusi EA; Louw C; Mastro TD; Smit J; Batting JR; Malahleha M; Bailey VC; Beksinska M; Donnell D; Baeten JM;
J Int AIDS Soc; 2020 May; 23(5):e25491. PubMed ID: 32396700
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
Mansoor LE; Lewis L; Naicker CL; Harkoo I; Dawood H; Naidoo K; Gengiah TN; Samsunder N; Beesham I; Abdool Karim SS; Abdool Karim Q
J Int AIDS Soc; 2022 Jul; 25(7):e25957. PubMed ID: 35785472
[TBL] [Abstract][Full Text] [Related]
6. Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa.
Joseph Davey DL; Mvududu R; Mashele N; Lesosky M; Khadka N; Bekker LG; Gorbach P; Coates TJ; Myer L
J Int AIDS Soc; 2022 Feb; 25(2):e25866. PubMed ID: 35138678
[TBL] [Abstract][Full Text] [Related]
7. Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial.
Beesham I; Mansoor LE; Joseph Davey DL; Palanee-Phillips T; Smit J; Ahmed K; Selepe P; Louw C; Singata-Madliki M; Kotze P; Heffron R; Parikh UM; Wiesner L; Rees H; Baeten JM; Beksinska M
J Acquir Immune Defic Syndr; 2022 Sep; 91(1):26-30. PubMed ID: 35972853
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
[TBL] [Abstract][Full Text] [Related]
10. Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa.
Beesham I; Dovel K; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
AIDS Behav; 2022 Sep; 26(9):3079-3087. PubMed ID: 35316471
[TBL] [Abstract][Full Text] [Related]
11. Key stakeholders' perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa.
Beesham I; Milford C; Joseph Davey DL; Smit J; Mansoor LE; Beksinska M
Afr J AIDS Res; 2023 Apr; 22(1):18-26. PubMed ID: 36951406
[No Abstract] [Full Text] [Related]
12. Recent Alcohol Use Is Associated With Increased Pre-exposure Prophylaxis (PrEP) Continuation and Adherence Among Pregnant and Postpartum Women in South Africa.
Miller AP; Shoptaw S; Moucheraud C; Mvududu R; Essack Z; Gorbach PM; Myer L; Davey DLJ
J Acquir Immune Defic Syndr; 2023 Mar; 92(3):204-211. PubMed ID: 36413977
[TBL] [Abstract][Full Text] [Related]
13. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study.
Donnell D; Beesham I; Welch JD; Heffron R; Pleaner M; Kidoguchi L; Palanee-Phillips T; Ahmed K; Baron D; Bukusi EA; Louw C; Mastro TD; Smit J; Batting JR; Malahleha M; Bailey VC; Beksinska M; Rees H; Baeten JM;
Lancet HIV; 2021 Aug; 8(8):e495-e501. PubMed ID: 34126052
[TBL] [Abstract][Full Text] [Related]
14. Uptake and continuation of HIV pre-exposure prophylaxis among women of reproductive age in two health facilities in Kisumu County, Kenya.
Ogolla M; Nyabiage OL; Musingila P; Gachau S; Odero TMA; Odoyo-June E; Ochanda B; Appolonia A; Katiku E; Joseph R; Ogolla C; Otieno L; Odhiambo F; Truong HM
J Int AIDS Soc; 2023 Mar; 26(3):e26069. PubMed ID: 36912204
[TBL] [Abstract][Full Text] [Related]
15. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
[TBL] [Abstract][Full Text] [Related]
16. Patterns of HIV Pre-exposure Prophylaxis use Among Adolescent Girls and Young Women Accessing Routine Sexual and Reproductive Health services in South Africa.
Martin CE; Cox LA; Nongena P; Butler V; Ncube S; Sawry S; Mullick S
J Adolesc Health; 2023 Dec; 73(6S):S81-S91. PubMed ID: 37953014
[TBL] [Abstract][Full Text] [Related]
17. Understanding Oral PrEP Interest, Uptake, Persistence, and Experience of Use Among Heterosexual Men in Johannesburg, South Africa: An Exploratory Pilot Study.
Felker-Kantor E; Greener LR; Mabaso S; Kruger W; Hasen N; Khosla A; Malone S
AIDS Behav; 2024 Feb; 28(2):564-573. PubMed ID: 38127167
[TBL] [Abstract][Full Text] [Related]
18. Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial.
Joseph Davey DL; Dovel K; Cleary S; Khadka N; Mashele N; Silliman M; Mvududu R; Nyemba DC; Coates TJ; Myer L
BMC Public Health; 2022 Jul; 22(1):1306. PubMed ID: 35799121
[TBL] [Abstract][Full Text] [Related]
19. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
[TBL] [Abstract][Full Text] [Related]
20. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme.
Kinuthia J; Pintye J; Abuna F; Mugwanya KK; Lagat H; Onyango D; Begnel E; Dettinger J; Baeten JM; John-Stewart G;
Lancet HIV; 2020 Jan; 7(1):e38-e48. PubMed ID: 31813837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
